ASA
TMO icon

Armstrong Shaw Associates’s Thermo Fisher Scientific TMO Stock Holding History

Armstrong Shaw Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-77,017
Closed -$10.9M – 47
2016
Q4 		$10.9M Sell
77,017
-2,954
-4% -$436K 2.58% 24
2016
Q3 		$12.7M Sell
79,971
-3,956
-5% -$610K 3.16% 16
2016
Q2 		$12.4M Sell
83,927
-95
-0.1% -$14K 3.16% 17
2016
Q1 		$11.9M Sell
84,022
-6,447
-7% -$864K 3.07% 15
2015
Q4 		$12.8M Sell
90,469
-2,975
-3% -$397K 3.03% 14
2015
Q3 		$11.4M Sell
93,444
-141
-0.2% -$18.4K 2.77% 18
2015
Q2 		$12.1M Buy
93,585
+716
+0.8% +$93.3K 2.63% 21
2015
Q1 		$12.5M Sell
92,869
-16,365
-15% -$2.11M 2.68% 22
2014
Q4 		$13.7M Sell
109,234
-3,851
-3% -$468K 2.48% 26
2014
Q3 		$13.8M Sell
113,085
-2,998
-3% -$365K 2.5% 23
2014
Q2 		$13.7M Sell
116,083
-61,094
-34% -$7.19M 2.48% 21
2014
Q1 		$21.3M Sell
177,177
-588,331
-77% -$69.9M 2.62% 21
2013
Q4 		$85.2M Buy
765,508
+987
+0.1% +$98.1K 3.15% 10
2013
Q3 		$70.5M Buy
764,521
+48,600
+7% +$4.4M 2.86% 16
2013
Q2 		$60.6M Buy
+715,921
New +$59.6M 2.53% 21

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Armstrong Shaw Associates's TMO Position: Q1 2017 in Review

Armstrong Shaw Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2017, closing a stake of 77,017 shares — an estimated $10.9M sold.

Armstrong Shaw Associates first reported a position in TMO in Q2 2013 and held it in 15 quarters. The position peaked at $85.2M in Q4 2013. 1,135 funds tracked by Wall St. Rank hold TMO as of Q1 2017.

  • Armstrong Shaw Associates reported no remaining Thermo Fisher Scientific position as of Q1 2017 after selling out during the quarter.
  • Armstrong Shaw Associates sold 77,017 Thermo Fisher Scientific shares in Q1 2017, an estimated $10.9M.
  • Armstrong Shaw Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 15 quarters.
  • Armstrong Shaw Associates's Thermo Fisher Scientific position peaked at $85.2M in Q4 2013.
  • 1,135 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2017.

Based on Armstrong Shaw Associates's 13F filing for Q1 2017, filed 27 Apr 2017.